Skip to Content

Hydrocortisone Topical Dosage

Applies to the following strength(s): 1% ; 0.5% ; 2.5% ; 25 mg ; valerate 0.2% ; 30 mg ; probutate 0.1% ; 2% ; 2% with cleanser ; butyrate 0.1% ; 2% with emollients ; valerate ; butyrate ; 10%

The information at Drugs.com is not a substitute for medical advice. ALWAYS consult your doctor or pharmacist.

Usual Adult Dose for:

Usual Pediatric Dose for:

Additional dosage information:

Usual Adult Dose for Dermatitis

Cream, ointment, solution, gel, or lotion: Apply to affected area two to four times a day

Comments:
-Occlusive dressings may be used for the management of psoriasis or other recalcitrant conditions.
-If an infection develops, the use of occlusive dressings should be discontinued and appropriate antimicrobial therapy initiated.
-The safety and efficacy of drug use for longer than 4 weeks have not been established.

Use: Relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses

Usual Adult Dose for Eczema

Cream, ointment, solution, gel, or lotion: Apply to affected area two to four times a day

Comments:
-Occlusive dressings may be used for the management of psoriasis or other recalcitrant conditions.
-If an infection develops, the use of occlusive dressings should be discontinued and appropriate antimicrobial therapy initiated.
-The safety and efficacy of drug use for longer than 4 weeks have not been established.

Use: Relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses

Usual Adult Dose for Psoriasis

Cream, ointment, solution, gel, or lotion: Apply to affected area two to four times a day

Comments:
-Occlusive dressings may be used for the management of psoriasis or other recalcitrant conditions.
-If an infection develops, the use of occlusive dressings should be discontinued and appropriate antimicrobial therapy initiated.
-The safety and efficacy of drug use for longer than 4 weeks have not been established.

Use: Relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses

Usual Adult Dose for Pruritus

Rectal Suppository: 25 mg inserted rectally once or twice a day
Maximum dose: The dose may be increased to 75 mg or 100 mg a day as needed.
Rectal foam: One applicatorful (80 mg) rectally once or twice a day
Cream: Apply three to four times a day

Comments:
-Rectal foam therapy should be continued for approximately 2 weeks.
-Sigmoidoscopy is recommended to judge dosage adjustment, duration of therapy, and rate of improvement.

Uses:
-Suppository: In inflamed hemorrhoids, post-irradiation (factitial) proctitis; as an adjunct in the treatment of chronic ulcerative colitis; cryptitis; and other inflammatory conditions of anorectum and pruritus ani
-Foam: Treatment of ulcerative proctitis of the distal portion of the rectum in patients who cannot retain hydrocortisone or other corticosteroid enemas
-Cream: Temporary relief of external anal itching; temporary relief of itching associated with minor skin irritations and rashes

Usual Adult Dose for Proctitis

Rectal Suppository: 25 mg inserted rectally once or twice a day
Maximum dose: The dose may be increased to 75 mg or 100 mg a day as needed.
Rectal foam: One applicatorful (80 mg) rectally once or twice a day
Cream: Apply three to four times a day

Comments:
-Rectal foam therapy should be continued for approximately 2 weeks.
-Sigmoidoscopy is recommended to judge dosage adjustment, duration of therapy, and rate of improvement.

Uses:
-Suppository: In inflamed hemorrhoids, post-irradiation (factitial) proctitis; as an adjunct in the treatment of chronic ulcerative colitis; cryptitis; and other inflammatory conditions of anorectum and pruritus ani
-Foam: Treatment of ulcerative proctitis of the distal portion of the rectum in patients who cannot retain hydrocortisone or other corticosteroid enemas
-Cream: Temporary relief of external anal itching; temporary relief of itching associated with minor skin irritations and rashes

Usual Adult Dose for Ulcerative Colitis

Rectal Suppository: 25 mg inserted rectally once or twice a day
Maximum dose: The dose may be increased to 75 mg or 100 mg a day as needed.
Rectal foam: One applicatorful (80 mg) rectally once or twice a day
Cream: Apply three to four times a day

Comments:
-Rectal foam therapy should be continued for approximately 2 weeks.
-Sigmoidoscopy is recommended to judge dosage adjustment, duration of therapy, and rate of improvement.

Uses:
-Suppository: In inflamed hemorrhoids, post-irradiation (factitial) proctitis; as an adjunct in the treatment of chronic ulcerative colitis; cryptitis; and other inflammatory conditions of anorectum and pruritus ani
-Foam: Treatment of ulcerative proctitis of the distal portion of the rectum in patients who cannot retain hydrocortisone or other corticosteroid enemas
-Cream: Temporary relief of external anal itching; temporary relief of itching associated with minor skin irritations and rashes

Usual Adult Dose for Hemorrhoids

Rectal Suppository: 25 mg inserted rectally once or twice a day
Maximum dose: The dose may be increased to 75 mg or 100 mg a day as needed.
Rectal foam: One applicatorful (80 mg) rectally once or twice a day
Cream: Apply three to four times a day

Comments:
-Rectal foam therapy should be continued for approximately 2 weeks.
-Sigmoidoscopy is recommended to judge dosage adjustment, duration of therapy, and rate of improvement.

Uses:
-Suppository: In inflamed hemorrhoids, post-irradiation (factitial) proctitis; as an adjunct in the treatment of chronic ulcerative colitis; cryptitis; and other inflammatory conditions of anorectum and pruritus ani
-Foam: Treatment of ulcerative proctitis of the distal portion of the rectum in patients who cannot retain hydrocortisone or other corticosteroid enemas
-Cream: Temporary relief of external anal itching; temporary relief of itching associated with minor skin irritations and rashes

Usual Pediatric Dose for Dermatitis

Cream, ointment, solution, gel, or lotion: Apply to affected area two to four times a day

Comments:
-Occlusive dressings may be used for the management of psoriasis or other recalcitrant conditions.
-If an infection develops, the use of occlusive dressings should be discontinued and appropriate antimicrobial therapy initiated.
-The safety and efficacy of drug use for longer than 4 weeks have not been established.

Use: Relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses

Usual Pediatric Dose for Eczema

Cream, ointment, solution, gel, or lotion: Apply to affected area two to four times a day

Comments:
-Occlusive dressings may be used for the management of psoriasis or other recalcitrant conditions.
-If an infection develops, the use of occlusive dressings should be discontinued and appropriate antimicrobial therapy initiated.
-The safety and efficacy of drug use for longer than 4 weeks have not been established.

Use: Relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses

Usual Pediatric Dose for Psoriasis

Cream, ointment, solution, gel, or lotion: Apply to affected area two to four times a day

Comments:
-Occlusive dressings may be used for the management of psoriasis or other recalcitrant conditions.
-If an infection develops, the use of occlusive dressings should be discontinued and appropriate antimicrobial therapy initiated.
-The safety and efficacy of drug use for longer than 4 weeks have not been established.

Use: Relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses

Usual Pediatric Dose for Pruritus

Rectal Suppository: 25 mg inserted rectally once or twice a day
Maximum dose: The dose may be increased to 75 mg or 100 mg a day as needed.
Rectal foam: One applicatorful (80 mg) rectally once or twice a day
Cream: Apply three to four times a day

Comments:
-Rectal foam therapy should be continued for approximately 2 weeks.
-Sigmoidoscopy is recommended to judge dosage adjustment, duration of therapy, and rate of improvement.

Uses:
-Suppository: In inflamed hemorrhoids, post-irradiation (factitial) proctitis; as an adjunct in the treatment of chronic ulcerative colitis; cryptitis; and other inflammatory conditions of anorectum and pruritus ani
-Foam: Treatment of ulcerative proctitis of the distal portion of the rectum in patients who cannot retain hydrocortisone or other corticosteroid enemas
-Cream: Temporary relief of external anal itching; temporary relief of itching associated with minor skin irritations and rashes

Usual Pediatric Dose for Proctitis

Rectal Suppository: 25 mg inserted rectally once or twice a day
Maximum dose: The dose may be increased to 75 mg or 100 mg a day as needed.
Rectal foam: One applicatorful (80 mg) rectally once or twice a day
Cream: Apply three to four times a day

Comments:
-Rectal foam therapy should be continued for approximately 2 weeks.
-Sigmoidoscopy is recommended to judge dosage adjustment, duration of therapy, and rate of improvement.

Uses:
-Suppository: In inflamed hemorrhoids, post-irradiation (factitial) proctitis; as an adjunct in the treatment of chronic ulcerative colitis; cryptitis; and other inflammatory conditions of anorectum and pruritus ani
-Foam: Treatment of ulcerative proctitis of the distal portion of the rectum in patients who cannot retain hydrocortisone or other corticosteroid enemas
-Cream: Temporary relief of external anal itching; temporary relief of itching associated with minor skin irritations and rashes

Usual Pediatric Dose for Ulcerative Colitis

Rectal Suppository: 25 mg inserted rectally once or twice a day
Maximum dose: The dose may be increased to 75 mg or 100 mg a day as needed.
Rectal foam: One applicatorful (80 mg) rectally once or twice a day
Cream: Apply three to four times a day

Comments:
-Rectal foam therapy should be continued for approximately 2 weeks.
-Sigmoidoscopy is recommended to judge dosage adjustment, duration of therapy, and rate of improvement.

Uses:
-Suppository: In inflamed hemorrhoids, post-irradiation (factitial) proctitis; as an adjunct in the treatment of chronic ulcerative colitis; cryptitis; and other inflammatory conditions of anorectum and pruritus ani
-Foam: Treatment of ulcerative proctitis of the distal portion of the rectum in patients who cannot retain hydrocortisone or other corticosteroid enemas
-Cream: Temporary relief of external anal itching; temporary relief of itching associated with minor skin irritations and rashes

Usual Pediatric Dose for Hemorrhoids

Rectal Suppository: 25 mg inserted rectally once or twice a day
Maximum dose: The dose may be increased to 75 mg or 100 mg a day as needed.
Rectal foam: One applicatorful (80 mg) rectally once or twice a day
Cream: Apply three to four times a day

Comments:
-Rectal foam therapy should be continued for approximately 2 weeks.
-Sigmoidoscopy is recommended to judge dosage adjustment, duration of therapy, and rate of improvement.

Uses:
-Suppository: In inflamed hemorrhoids, post-irradiation (factitial) proctitis; as an adjunct in the treatment of chronic ulcerative colitis; cryptitis; and other inflammatory conditions of anorectum and pruritus ani
-Foam: Treatment of ulcerative proctitis of the distal portion of the rectum in patients who cannot retain hydrocortisone or other corticosteroid enemas
-Cream: Temporary relief of external anal itching; temporary relief of itching associated with minor skin irritations and rashes

Usual Pediatric Dose for Atopic Dermatitis

Apply a thin film to the affected skin areas two times a day

Comments:
-Cream should not be used with occlusive dressings or applied in the diaper area unless directed by a healthcare provider.

Use: Treatment of mild to moderate atopic dermatitis in pediatric patients 3 months to 18 years of age

Renal Dose Adjustments

Data not available

Liver Dose Adjustments

Data not available

Precautions

Safety and efficacy have not been established in patients younger than 3 months.

Consult WARNINGS section for additional precautions.

Dialysis

Data not available

Other Comments

Administration advice:
-The treated area should not be bandaged, covered, or wrapped, as to be occlusive, unless directed by a healthcare provider.
-Parents of pediatric patients should be advised not to use tight-fitting diapers or plastic pants on a child being treated in the diaper area.

Storage requirements:
-Excessive heat and freezing should be avoided.
-The aerosol container should not be stored at temperatures above 120F (48.8C).

Monitoring:
-Endocrine: HPA-axis suppression (Urinary free-cortisol test, ACTH-stimulation test)

Patient advice:
-Patients should report any signs of local adverse reactions, especially those that develop under occlusive dressings.
-This medication is to be used as directed by the physician.
-Patients should be advised not to use this medication for any condition other than for which it was prescribed.

Hide